Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review

To review objectively the evidence for the use of bisphosphonates for the reduction of skeletal events or the management of pain due to multiple myeloma or bone metastases from other types of cancer. MEDLINE was searched from 1976 onwards using the MeSH terms "exp diphosphonates/," "e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 1998-03, Vol.16 (3), p.1218-1225
1. Verfasser:	BLOOMFIELD, D. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics, Non-Narcotic - therapeutic use Biological and medical sciences Bone Neoplasms - complications Bone Neoplasms - drug therapy Bone Neoplasms - secondary Bones, joints and connective tissue. Antiinflammatory agents Breast Neoplasms - pathology Clodronic Acid - therapeutic use Diphosphonates - therapeutic use Evidence-Based Medicine Female Humans Male Medical sciences Multiple Myeloma - complications Multiple Myeloma - drug therapy Other treatments Pain - drug therapy Pain - etiology Pharmacology. Drug treatments Practice Guidelines as Topic Prostatic Neoplasms - pathology Randomized Controlled Trials as Topic Treatment. General aspects Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!